Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s just the CEO of a promising biotech telling a story since no one wants to print it….YET.
Imagine the response if Missling calmly got to the mic, held up a pill of Blarcamesine and said;
What if I were to tell you, this little pill(holding up for camera to see), could potentially change MILLIONS of lives…..for the better!
One day soon…….hopefully
Wonder how each of the other trial positive/negative results affect that 60% for Alzheimer’s?
I do agree that when it’s time for “the” move, this is what will occur. Everyone expecting a pullback but it never occurs, until way later.
Then again, I thought that moment was upon us a few times already.
In that case, programmers did a number on the crypto market a few days ago.
Feels like we are being cradled and being rocked back and forth to sleep.
Can’t we wake up and it’s Dec 2022 already.
Woke up, looked for news, saw none, sold trading shares, bought back for a gain of 25 shares in the 401k.
Wish I started a long time ago.
There WAS that one article discussing the chart of “it” and the author said it looked like teens was the target.
Think it was on SA
Blotting the blot chart, what a great idea.
Good call on the SAVA rug last week. I know you were mentioning it over and over but there were those here that were debating against that happening.
Have to admit it though. That CEO may/may not go to jail, but I bet he made out like a bandit
The LONG game
2 more years can’t come soon enough
IF it plays out that way, I’m pretty sure a few on the board will have sold too early.
What IS the real value of a magic pill for the entire CNS? Speculating they run the table and it’s a one stop shop including prevention?
$1249 seems too low as well.
That’s a topic when/if Anavex gets at least a 1/4 of the way there.
You can hear the argument now.
If ANVS and SAVA fails/manipulate data, why would AVXL be any different.
If BP can’t solve it, you think a tiny $1.5B market cap company can.
Sure glad Anavex is no longer riding anyone’s “coattail”
That’s what I tried, playing with 500 shares. What do I have to show for it….15 extra shares.
Guess that’s 15 shares I didn’t need to purchase.
You know the drill…..
How is it possible that this tiny company, trading at $18, do what BP has been trying to do for the last 10,20,30 years?
You know what they say about something that sounds too good to be true……
Or maybe…………they thought outside of the box? Went against the norm?
A-273 keeps adding more and more “,” to the list of possible beneficial for.
I don’t even wanna think about what the sp could be.
Data for Rett, PD, ALZ first…
If those all hit the mark….. maybe we’ll get to $45 *sarcastic*
Dead money for years to come now SAVA is.
Much like how Anavex was the last few years. The box is finally soon ready to be opened and data revealed.
I’ll throw in a stink bid in high 16s JUST in case.
I guess you didn’t see what I did there with that line
“Anavex and CEO Missling has never been rejected by the FDA.”
Looks like we go lower tomorrow. And that’s fine with me.
Good luck to you and may your trades be fruitful.
Anavex CEO Missling has NEVER been rejected by the FDA.
Cassava, AKA Pain Therapeutics, and CEO Remi Barbier has been rejected a total of 4 times.
Who is it that said the following?
“Remoxy remains an odyssey without a homecoming. We had hoped for a fair, neutral and impartial review of the Remoxy data. Instead, we walked out of this meeting feeling a bit disoriented by FDA’s lack of transparency, clarity or helpfulness. It’s a rare occasion when two parties can’t agree on simple math. We can’t work with shambolic regulations. This is not how you win support for innovation.”
Yea…. Ceo of Cassava in their previous name Pain Therapeutics.
This is the guy that is the competition….?
Yea, I know where I’ll keep my $$ at.
https://endpts.com/a-disoriented-pain-therapeutics-flips-out-after-fda-rejects-appeal-on-remoxy/
Now now Falconer, remember what “they” said about that last time…….
It may be an agreed on target, but time will tell which will benefit the patient most. It’s what these companies want right…..
What’s best for the patient.
Actions speak louder than PR Kund. I’ll believe it when I see it.
Cassava will be PRing the hell for next 3 years while enrolling and readout of data.
Meanwhile Anavex has its candidate in multiple P2/3 P3 trials.
I agree the rug will be pulled for SAVA bunch
Those Jan 2023 calls look tempting
At least make the lies believable
Nah, the ignorant.
Perfect example is this…..if it was SAVA or BIIB or “fill in the blank” with said news, how would the reaction be different?
Ha. I sold my trading shares at 19.20s a few days ago knowing that I’d buy back in the 17s when it got that low.
$15s?
It’s what they want us to believe. At least they are acknowledging that yes, it might possibly get approved, but you’ll still have to wait years for production to start up.
Curious how fast that million took to make a year or two ago.
Remember 2 before 11
Wonder what the angle will be once p2/3 top line is revealed.
Misdiagnosed maybe….
Sure doesn’t act like a CEO with a revolutionary pill.
Probably will have the same “it’s my job” attitude when the co is worth 5,10,15, BILLION.
Well, I’m in my low 40s but would most definitely take Blarcamesine as a preventative.
I don’t think Missling is in any rush to get AVXL higher. He’ll let the trial results speak for themself. 3 trial readouts,2 of which are BIG Potential, within the next 365 days…..?
I’m glad I was able to still gather another 1500 shares over the last 2 trading days.
Tom, I think some people like to play Sunday Quarterback and select their “sell” and “buy” after the fact.
It shows ones true character when another company got you beat. They still discount said company for what they accomplished because you couldn’t do it the last 20 years.
At least we know how soon SAVA will complete enrollment of their Alz trial. KINDA SOON. So really really….not soon at all.